(redirected from Non-Small Cell Lung Carcinoma)
NSCLCNon Small Cell Lung Cancer
NSCLCNon-Small Cell Lung Carcinoma (medical condition)
NSCLCNational Senior Citizens Law Center
NSCLCNorth Shepparton Community & Learning Centre (Australia)
NSCLCNorth Sefton City Learning Centre (Aisdale, Southport, UK)
NSCLCNapa-Solano Central Labor Council (California)
References in periodicals archive ?
It is intended for the qualitative detection of the anaplastic lymphoma kinase (ALK) protein in formalin-fixed, paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC) tissue stained with a BenchMark XT or BenchMark ULTRA automated staining instrument.
Several immune checkpoint inhibitors that target the interaction between programmed death receptor-1 (PD-1) and programmed death ligand-1 (PD-L1) have been successful in clinical trials for the treatment of non-small cell lung carcinoma (NSCLC).
One patient with non-small cell lung carcinoma (NSCLC), showed partial response and four patients (one each with thyroid, prostatic, pancreatic carcinoma and peritoneal mesothelioma) showed long-term disease stabilisation for up to 14 months.
will sponsor and manage a phase 1/2a clinical trial of AST-VAC2 in patients with non-small cell lung carcinoma.
Patients had different histologies but majority were non-small cell lung carcinoma (NSCLC) (n=145; 80.
High number of tumour-infiltrating lymphocytes is associated with apoptosis in non-small cell lung carcinoma.
It demonstrates high accuracy in distinguishing between small cell lung carcinoma and non-small cell lung carcinoma, a clinically important differentiation.
In late 2011, Axelar plans to start a phase II programme to test AXL1717 in patients suffering from non-small cell lung carcinoma (NSCLC).
The current study went a step further and showed that a-CbT could inhibit non-small cell lung carcinoma (NSCLC) growth and prolong life in non-obese/severe combined immunodeficient (NOD/SCID) mice that had human NSCLC grafted to their lungs.
The dichloromethane and n-butanol extracts obtained from fresh bulbs of Hippeastrum vittatum (Amaryllidaceae), collected in Southern Brazil, were evaluated for their cytotoxic activity in vitro against five human cell lines (HT29 colon adenocarcinoma, H460 non-small cell lung carcinoma, RXF393 renal cell carcinoma, MCF7 breast cancer, and OVCAR3 epithelial ovarian cancer), using the sulphorhodamine B assay.
Future trials will focus on treating multiple myeloma and non-small cell lung carcinoma.
18]fluorodeoxyglucose PET scans with CT images may supply the best information for maximizing treatment planning in patients with non-small cell lung carcinoma, a multicenter French study showed.